PACB — PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1299130 ·
Last close
$1.62
Market Cap
$503.55M
52W High
$2.73
52W Low
$1.07
ADV30
6,335,587
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 37,178,000 | 12,841,000 | -54,153,000 | -8,275,000 | 782,365,000 | 56,274,000 | 779,999,000 |
| Dec 2025 | 44,645,000 | 16,566,000 | -41,197,000 | -40,371,000 | 784,083,000 | 63,707,000 | 778,734,000 |
| Sep 2025 | 38,441,000 | 15,901,000 | -38,877,000 | -38,000,000 | 803,158,000 | 56,467,000 | 767,068,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-111,844,000
Investing CF
$106,073,000
Financing CF
$2,906,000
CapEx
$-15,843,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.43
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,748,318,000
Inventory
$61,084,000
Receivables
$31,104,000
ST Investments
$175,870,000
EBIT TTM
$-123,231,000
Pretax Income TTM
$-130,560,000
Interest Exp TTM
$7,329,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$159,271,008
EBITDA
$199,176,000
Free Cash Flow
$291,644,736
Enterprise Value
$876,334,016
Total Cash
$236,872,992
Total Debt
$709,126,976
Shares Out
310,830,759
Trailing EPS
$-0.42
Book Value
$-0.11
ROE
-929.3%
ROA
-14.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 160,005,000 | -557,561,000 | -546,376,000 | 784,083,000 | 778,734,000 | 5,349,000 | -111,209,000 |
| Dec 2024 | 154,014,000 | -290,663,000 | -309,851,000 | 1,260,447,000 | 753,853,000 | 506,594,000 | -206,058,000 |
| Dec 2023 | 200,521,000 | -310,365,000 | -306,735,000 | 1,746,013,000 | 1,044,709,000 | 701,304,000 | -259,173,000 |
| Dec 2022 | 128,304,000 | -304,819,000 | -314,248,000 | 1,767,086,000 | 1,204,182,000 | 562,904,000 | -263,211,000 |
TTM Snapshot
Revenues TTM
$165,122,000
NetIncome TTM
$-630,640,000
OpCashFlow TTM
$0
Assets (Latest)
$784,083,000
Forward EPS
$-0.40
Max Pain — expiry 2026-12-18
max pain strike: $1.50 · spot: $1.62 · call oi: 7,514 · put oi: 470
Expected Move to 2026-12-18:
±$0.44
(27.16%) —
implied range
$1.18 –
$2.06
· ATM straddle on $1.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IGD | Voya GLOBAL EQUITY DIVIDEND & PREMIUM OPPORTUNITY FUND | $502.39M | $6.37 | — |
| ETO | Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund | $498.69M | $30.43 | — |
| BGB | Blackstone Strategic Credit 2027 Term Fund | $496.38M | $11.11 | — |
| VGM | Invesco Trust for Investment Grade Municipals | $494.60M | $9.12 | — |
| ONT | Onterris, Inc. | $491.64M | $14.00 | — |
News headlines (Yahoo Finance, 1h cache)
Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know
2026-09-25 21:15 · Yahoo
Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push
2026-09-20 06:02 · Yahoo
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
2026-09-17 22:15 · Yahoo
Q2 Earnings Highlights: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks
2026-09-08 16:23 · Yahoo
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
2026-09-04 15:30 · Yahoo
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
2026-09-03 20:05 · Yahoo
3 Unprofitable Stocks That Fall Short
2026-09-25 15:12 · Yahoo
1 Stock Under $10 with Exciting Potential and 2 We Avoid
2026-09-24 12:24 · Yahoo
2 Small-Cap Stocks for Long-Term Investors and 1 Facing Headwinds
2026-09-21 10:38 · Yahoo
3 Cash-Burning Stocks We Approach with Caution
2026-09-14 15:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.